News

A “disgraceful decision:” Researchers blast FDA for approving Alzheimer’s drug

Arstechnica

Even the FDA's own advisers and statisticians didn't think the drug should be approved.

Visit Site

We made a PlayStation Plus explainer that’s better than Sony’s [Updated]Arstechnica President Biden to host infosec roundtable with tech giant CEOsArstechnica Climate stakes are high for ice and oceans, IPCC report explainsArstechnica SpaceX slams Dish’s “baseless attempt” to block Starlink’s FCC fundingArstechnica Quake “enhanced” re-release out before it’s announced (with Quake 64, too)Arstechnica Today’s massive Internet outage comes courtesy of Akamai Edge DNSArstechnica How a top tier European soccer team sped up their data processing and reduced costs by 50%Modal Anthropic integration with Modal brings scalable compute to Claude ScienceModal KAUST and Cerebras Named Gordon Bell Award Finalist for Solving Multi-Dimensional SeismicCerebras Speech-to-Text API model for Pharma Use Cases | Nova-3 PharmaDeepgram Policy as Code for Any Cloud ProviderPulumi Sparsity Made EasyCerebras University of Minnesota Researchers Tried to Poison the Linux KernelThenewstack Context is Everything: Why Maximum Sequence Length Matters - CerebrasCerebras Agent architecture: How AI decision-making drives business impactRetool Deceptive Deprecation: The Truth About npm Deprecated PackagesAquasec Gafgyt Malware Variant Exploits GPU Power and Cloud Native EnvironmentsAquasec Innovative AI Projects land in Edinburgh - CerebrasCerebras Socket Acquires Coana to Bring Best-in-Class Reachability Analysis to Next-Gen SCASocket 19 Chrome and Edge Extensions Deliver a Wallet Drainer and Credential-Stealing PayloadsSocket